Inferensys

Service

Generative Protein Design Engineering

Build AI systems that generate novel, stable, and functional protein sequences for therapeutic, industrial, and diagnostic applications, moving beyond prediction to de novo creation.
Overhead shot of a beautifully lit strategy meeting in a modern WeWork hot desk area, designers and executives gathered around a live AI system diagram projected on smart table surface.
GENERATIVE BIOLOGY

The Challenge of Novel Protein Discovery

Accelerate therapeutic and industrial innovation by moving from protein prediction to AI-driven de novo design.

Traditional protein engineering is a slow, trial-and-error process limited by natural sequence space. Our generative AI systems bypass this bottleneck, creating novel, stable, and functional protein sequences with desired properties from first principles.

We architect AI workflows that generate, simulate, and prioritize candidates, reducing discovery cycles from years to months and delivering lab-validated leads.

  • De Novo Sequence Generation: Leverage models like ProteinMPNN and RFdiffusion to design proteins for specific binding, catalysis, or stability targets.
  • In Silico Validation: Use molecular dynamics simulations and AlphaFold2 structure prediction to computationally screen for expression viability and function before synthesis.
  • Multi-Property Optimization: Simultaneously optimize for thermostability, solubility, and low immunogenicity using multi-objective reinforcement learning.
FROM SEQUENCE TO SOLUTION

Business Outcomes of AI Protein Design

Move beyond academic prediction to de novo creation of functional proteins. Our engineering service delivers validated, production-ready protein sequences that directly translate into therapeutic, industrial, and diagnostic applications.

01

Accelerated Therapeutic Discovery

Generate novel, stable protein candidates for biologics, enzymes, and vaccines in weeks, not years. We engineer sequences with optimized binding affinity, solubility, and immunogenicity profiles, de-risking your preclinical pipeline. Learn more about our approach to AI-driven drug discovery.

> 10x
Faster lead generation
Weeks
To validated candidates
02

Industrial Enzyme Optimization

Design enzymes with enhanced catalytic activity, thermal stability, and substrate specificity for green chemistry and biomanufacturing. Our generative workflows create variants tailored to your process conditions, delivering measurable improvements in yield and efficiency. Explore our specialized generative AI for enzyme engineering.

> 90%
Activity retention
> 60°C
Thermal stability
03

De Novo Diagnostic & Sensor Design

Create entirely new protein-based biosensors and diagnostic reagents with high specificity and low cross-reactivity. We generate binding domains for novel epitopes or non-immunogenic tags, enabling next-generation point-of-care and lab-based assays.

pM-nM
Target affinity
< 5%
Cross-reactivity
04

Reduced R&D Costs & Risk

Shift from expensive, iterative wet-lab screening to AI-driven in silico design. Our platform prioritizes synthesizable, expressible sequences with high predicted functionality, dramatically reducing the number of physical experiments required for validation.

> 70%
Fewer wet-lab cycles
$M+
Potential cost savings
05

IP-Generating Novelty

Secure strong, defensible intellectual property with protein sequences that are novel, non-obvious, and have demonstrable utility. Our generative models explore vast, untapped regions of protein space to deliver compositions not found in nature.

100% Novel
Sequence space
Strong Filing
IP Position
From Discovery to Deployed Model

Typical Development Timeline & Deliverables

A clear roadmap for developing a custom generative protein design system, from initial concept to a validated, production-ready AI model.

Phase & Key ActivitiesTimelineCore DeliverablesClient Involvement

Discovery & Problem Scoping

1-2 weeks

Technical requirements document, data readiness assessment, success metrics definition

Provide domain experts, access to legacy data, define target protein properties

Data Pipeline & Featurization Engineering

2-3 weeks

Cleaned, annotated training dataset, scalable ETL pipeline, molecular feature library

Approve data schemas, provide feedback on feature relevance

Model Architecture Design & Initial Training

3-4 weeks

Customized model architecture (e.g., ProteinMPNN/ESM-2 variant), initial performance benchmarks

Review architectural choices, validate biological plausibility of early outputs

Iterative Optimization & In-Silico Validation

4-6 weeks

Fine-tuned model, stability/functionality predictions, generated sequence library (1000s of candidates)

Prioritize candidate sequences for wet-lab testing, provide feedback on failure modes

Deployment & Integration (MLOps)

2-3 weeks

Containerized inference API, model monitoring dashboard, integration documentation

Provide staging environment, approve deployment architecture

Ongoing Support & Model Refinement

Ongoing (Optional SLA)

Monthly performance reports, retraining pipelines, access to model updates

Share wet-lab validation results, identify new design objectives

DELIVERING TANGIBLE VALUE

Industry Applications & Use Cases

Our generative protein design engineering services translate advanced AI into validated, functional proteins that accelerate R&D timelines and de-risk therapeutic and industrial development. We focus on delivering lab-ready sequences with measurable outcomes.

01

Novel Therapeutic Protein Design

De novo generation of stable, high-affinity antibody candidates, cytokine variants, and enzyme therapeutics with optimized pharmacokinetic properties. We deliver sequences pre-validated for expression yield and structural stability, reducing early-stage discovery cycles from months to weeks.

Learn more about our approach to AI-Driven Drug Discovery Platform Development.

4-8 weeks
Lead candidate generation
>70%
Expression success rate
02

Industrial Enzyme Optimization

AI-driven engineering of enzymes for enhanced catalytic activity, thermostability, and substrate specificity in biomanufacturing, bioremediation, and green chemistry. Our models predict mutations that achieve target performance metrics, bypassing costly high-throughput screening.

This work is complemented by our dedicated Generative AI for Enzyme Engineering service.

10-100x
Activity improvement
< 20 variants
For lab validation
03

Diagnostic & Biosensor Protein Engineering

Design of highly specific protein binders and reporters for point-of-care diagnostics, in vivo imaging, and environmental monitoring. We generate proteins with tailored binding kinetics and fusion compatibility for integration into sensor platforms.

pM-nM
Target affinity range
ISO 13485
Development framework
04

De Novo Protein Scaffold Creation

Generation of entirely novel protein folds and scaffolds not found in nature, creating blank-slate platforms for multi-specific biologics, drug delivery vehicles, and advanced biomaterials. This unlocks functionality beyond the constraints of natural protein families.

Stable
Computational design
Custom
Topology & symmetry
05

Vaccine Antigen & Immunogen Design

Computational design of immunogens that elicit potent and broad neutralizing antibody responses against viral pathogens and cancers. Our AI models optimize for structural mimicry of native epitopes while enhancing stability and manufacturability.

Validated
Epitope presentation
GMP-ready
Sequence data package
06

Protein-Protein Interaction Inhibitors

Rational design of peptides and miniproteins that disrupt pathogenic protein-protein interactions (PPIs) considered 'undruggable' by small molecules. Our generative models explore conformational space to identify tight-binding interfaces.

This often leverages insights from our Graph Neural Network Solutions for Biological Networks.

< 50 aa
Typical design size
IC50 < 1 µM
Computational target
Technical and Commercial Considerations

Frequently Asked Questions on AI Protein Design

Common questions from CTOs and R&D leaders about partnering with Inference Systems for generative protein design projects.

Our standard engagement delivers a shortlist of high-confidence, novel protein sequences in 4-6 weeks. This includes data pipeline setup, model fine-tuning or training, and in-silico validation (stability, solubility, function prediction). Lab validation partnerships extend the timeline based on experimental throughput, but we architect the computational workflow for rapid iteration.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.